Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Pulmatrix | PULM | Dec 24, 2024 | 6.06 | +5.25 |
Pulmonx | LUNG | Dec 24, 2024 | 6.16 | -1.60 |
Pulse Biosciences | PLSE | Dec 24, 2024 | 18.33 | +5.34 |
PulteGroup | PHM | Dec 24, 2024 | 110.75 | +0.56 |
Puma Biotechnology | PBYI | Dec 24, 2024 | 3.02 | +7.47 |
Pure Cycle | PCYO | Dec 24, 2024 | 12.87 | +1.50 |
Pure Storage A | PSTG | Dec 24, 2024 | 64.75 | +1.49 |
PureCycle Technologies | PCT | Dec 24, 2024 | 10.70 | +0.75 |
PureCycle Technologies Unit | PCTTU | Dec 24, 2024 | 15.72 | 0.00 |
Purefunds ISE Junior Silver [Sm | SILJ | Dec 24, 2024 | 10.95 | +0.37 |
PureTech Health ADR | PRTC | Dec 24, 2024 | 19.92 | 0.00 |
Purple Biotech ADR | PPBT | Dec 24, 2024 | 3.82 | +3.24 |
Purple Innovation | PRPL | Dec 24, 2024 | 0.89 | +0.13 |
Putnam Managed Municipal Income Trust | PMM | Dec 24, 2024 | 6.05 | 0.00 |
Putnam Master Intermediate Income Trust | PIM | Dec 24, 2024 | 3.29 | +0.61 |
Putnam Municipal Opportunities Trust | PMO | Dec 24, 2024 | 10.12 | +0.05 |
Putnam Premier Income Trust | PPT | Dec 24, 2024 | 3.58 | +0.28 |
PVH | PVH | Dec 24, 2024 | 108.62 | +1.10 |
Pyrophyte Acquisition | PHYT | Dec 24, 2024 | 11.55 | 0.00 |
Pyxis Oncology | PYXS | Dec 24, 2024 | 1.60 | -4.19 |
Pyxis Tankers | PXS | Dec 24, 2024 | 3.77 | +2.45 |
Q2 | QTWO | Dec 24, 2024 | 104.76 | +1.02 |
Q32 Bio | QTTB | Dec 24, 2024 | 3.31 | +2.48 |
QCR | QCRH | Dec 24, 2024 | 81.85 | +0.23 |
QIAGEN | QGEN | Dec 24, 2024 | 45.06 | +0.54 |
Qifu Technology ADR | QFIN | Dec 24, 2024 | 38.00 | -0.52 |
QMMM | QMMM | Dec 24, 2024 | 0.60 | -1.64 |
Qomolangma Acquisition | QOMO | Dec 24, 2024 | 11.55 | 0.00 |
Qorvo | QRVO | Dec 24, 2024 | 71.50 | -0.06 |
QT Imaging | QTI | Dec 24, 2024 | 0.35 | -7.89 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.